Current Issues of Pharmacy and Medical Sciences

Diagnosis of experimental stetohepatosis using ultrasound shear wave elastography

Current Issues in Pharmacy and Medical Sciences Vol. 26, No. 1, Pages 109-113


1 National Bohomolets University, Kiev, Ukraine
2 UNN «Biology lnstitute» of Kiev National Shevchenko University, Ukraine
3 Medical theoretical and practical association «Medstroj», Ukraine
4 Lviv National Medical University of Danylo Galytsky, Ukraine

DOI: 10.12923/j.2084-980X/26.1/a.24



According to available literature data, NAFLD may play crucial role in the pathogenesis of type 2 diabetes and other conditions connected with insulin resistance. In order to study the essence of the NAFLD, we have created an experimental model of the steatohepatosis. The mixed diet for 8 weeks consisting of standard food (47%), sweetened condensed milk (44%), vegetable oil (8%) and vegetable starch (1%) develops non-alcoholic steatohepatosis in the animals undergoing the experiment. The morphological signs of the non-alcoholic steatohepatosis comprised as follows in the hepatocytes of the rats undergoing the experiment: presence of fine-drop fattiness (fine-drop steatosis) and accumulation of fat vacuoles shifting the nucleus towards the cell peripheral. Substantial increase in the liver pulp of the animals undergoing the experiment defined using the ultrasound shear wave elastography technique is indicative of the presence of the non-alcoholic steatohepatosis. The ultrasound shear wave elastography technique can be used as a non-invasive diagnosis marker of the non-alcoholic steatohepatosis. The said diagnosis technique has been recommended for the first time.


steatohepatosis, non-alcoholic fatty liver disease, ultrasound liver elastography


  1. Angulo P.: Nonalcoholic fatty liver disease. N. Engl. J. Med., 346, 1221, 2002.
  2. Castera L., Negre I., Samii K., Buffet C.: Pain experienced during percutaneous liver biopsy. Hepatology, 30, 1529, 1999.
  3. Day C.P.: Pathogenesis of steatohepatitis. Best. Pract. Res. Gin. Gastroenterol., 16, 663, 2002.
  4. Fishbein M., Castro F., Cheruku S., Jain S., Webb B., et al.: Hepatic MRI for fat quanlitation: its relationship to fat morphology, diagnosis and ultrasound. J. Clin. Gastroenterol., 39, 619, 2005.
  5. Foucher J., Castera L., Bernard P.H. et al.: Prevalence and factors associated with failure of liver stiff ness measurement using FibroScan in a prospective study of 2114 examinations. Eur. J. Gastroenterol. Hepatol., 18, 411, 2006.
  6. Ganne-Carrie N., Ziol M., de Ledinghen V. et al.: Accuracy of liver stiffness measurement for the diagnosis  of cirrhosis   in   patients  with  chronic   liver diseases. Hepatology. 44, 1511, 2006.
  7. Joy D., Thava V.R., Scott B.B.: Diagnosis of fatty liver disease: is biopsy necessary? Kur. J. Gastroenterol. Hepatol., 15, 539, 2003.
  8. Liu С.Н., Hsu S.J., Lin J.W., Hwang J.J., Liu C.J. et al.: Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis С by splenic Doppler impedance index. Clin. Gastroenterol. Hepatol. 5, 199, 2007.
  9. Mottin C.C., Moretto M., Padoin A.V., Swarowsky A.M. et al.: The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes. Surg., 14, 635, 2004.
  10. Roulot D., Czernichow S., Le Clesiau I.I., Costes J.L. et al.: Liver stiffness  values  in  apparently  healthy  subjects:   influence  of gender and metabolic syndrome. J. Hepatol. Apr. 48, 606, 2008.
  11. Ryan C.K., Johnson L.A., Germin B.l., Marcos A.: One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl., 8, 1114, 2002.
  12. Saadeh S., Younossi Z.M., Reiner E.M., Gramlich Т., Ong J.P., Hurley M. et al.: The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology, 123, 745, 2002.
  13. Sandrin L., Fourquet B., Hasquenoph J.M. et al.: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound. Med. Biol., 29, 1705, 2003.
  14. Targher G., Arcaro G.: Non-alcoholic fatty liver disease an increased risk of cardiovascular disease. Atherosclerosis, 191, 235, 2007.
  15. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L. et al.: Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among. Type 2 diabetic patients. Diabetes Care, 30, 1212, 2007.
prev next



July 2020

Mon Tue Wed Thu Fri Sat Sun
    01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31